Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > NCIB Repurchase Stopped in July?

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jul 30, 2023 7:26am

86 Views

Post# 35563608

RE:RE:RE:RE:NCIB Repurchase Stopped in July?

OMG GUD has not made a profit in ten years ans the share price stand at 4.80 more or less as when the company became public. About 8 Year ago the share price were $10.50 and sicne it has been declining. GUD is mosly invested in inflaion and currency devaluations LATAM nation. The are the facts and long standing share hoders "bag holders" have lost fortunes. Yet Goldinvestor .. I would say " rustyinvestor" with the same DNA of Bugsy, Michy and Mugsy wouls like readers to believe otherwise.
At the end of the day all boils down to share price. The market says that GUD is worth $4.80 and going lower.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market